Search Results for “Case study - Ambassador” - Page 3

Ambassadors

Here at Retina UK we have some truly amazing volunteer Ambassadors, who help to spread the word about our important work and share their inspirational stories.

Funding paves the way for achromatopsia

A research project funded by Retina UK helped pave the way to a new gene therapy that has recently produced encouraging results in two young people with achromatopsia, a condition that causes complete colour-blindness and poor overall vision from birth.

Meet our Ambassador: Steve Bate MBE

Steve is a Paralympian who was diagnosed with retinitis pigmentosa (RP) in 2011.

An Asian woman looking at the camera. She is wearing a yellow shirt and her hair is falling over her left shoulder

Meet our Ambassador: Bhavini Makwana

Her work with us enables her to achieve her aim of empowering others living with similar conditions to her own.

A large group of Retina UK volunteers standing outside in the sunshine

Volunteer Impact Report

Our volunteers are highly valued members of the Retina UK team and their roles are essential to help support and enable people affected by inherited sight loss to live fulfilling lives.

x-linked inheritance

X-linked inheritance means that the faulty gene is located on the X chromosome, the larger of the two sex chromosomes.

Gene Therapy improves functional measures in XLRP

Beacon Therapeutics announced positive results from their phase 2 gene therapy trial for X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene.

Significantly worse vision found in female carriers of X-linked RP and Choroideremia

It was previously believed that female carriers of X-linked inherited retinal diseases (IRDs) like X-linked retinitis pigmentosa (RP and Choroideremia) remained unaffected by sight loss.

Two women, one standing and one seated. The seated women has her face in a device on the wall

Brain stimulation may reduce hallucinations

UK researchers have discovered that passing a weak electrical current between electrodes on a person’s scalp may lead to a reduction in frequency of the visual hallucinations experienced by some people living with sight loss.

Antabuse moves into clinical trial for people with RP

Disulfiram (Antabuse), FDA-approved for deterring alcohol, is in a phase 1 trial at the University of Washington to improve vision in retinitis pigmentosa.